Serum soluble interleukin-2 receptor, interleukin-6 and tumor necrosis factor alpha as markers of celiac disease activity

Indian Journal of Pediatrics

Volumn 80, Issue 2, 2013, Pages 108-113

  Kapoor, Akshay ^a,c   Patwari, A K ^a   Kumar, Praveen ^a   Jain, Anju ^b   Narayan, Shashi ^b  

^a KALAWATI SARAN CHILDREN'S HOSPITAL   (India)

^b LADY HARDINGE MEDICAL COLLEGE   (India)

^c NONE   (India)

Author keywords

Anti trans tissueglutaminase (TTG); Celiac disease; Gluten free diet; Interleukin 6(IL 6); Marsh grade; Serum soluble interleukin 2Receptor (sIL 2R); Tumor necrosis factor Alpha (TNF )

Indexed keywords

INTERLEUKIN 6; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; SOLUBLE INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GLUTEN FREE DIET; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSTIMULATION; MALE; PATIENT ASSESSMENT; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SEROLOGY; T LYMPHOCYTE ACTIVATION;

EID: 84877047031     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-012-0830-9     Document Type: Article

References (35)

1. Marsh MN. Gluten, major histocompatibility complex and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity. Gastroenterol. 1992;102:330-54.
2. Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not at-risk groups in the US. Arch Intern Med. 2003;163:286-92.
3. Mäki M, Mustalahti K, Kokkonen J, et al. Prevalence of coeliac disease in Finnish children. N Eng J Med. 2003;348:2517-24.
4. Walia BN, Sidhu JK, Tandon BN, Ghai OP, Bhargava S. Celiac disease in North Indian children. Br Med J. 1966;2:1233-4.
5. Khoshoo V, Bhan MK, Puri S. Serum anti-gliadin antibody profile in childhood protracted diarrhea due to celiac disease and other causes in a developing country. Scand J Gastroenterol. 1989;24:1212-6.
6. Sood A, Midha V, Sood N, Kaushal V, Puri H. Increasing incidence of celiac disease in India. Am J Gastroenterol. 2001;96:2804-5.
7. Yaccha SK, Misra S, Malik AK, Nagi B, Mehta S. Spectrum of malabsorption syndrome in North Indian children. Indian J Gastroenterol. 1993;12:120-5.
8. Patwari AK, Anand VK, Kapur G, Narayan S. Clinical and nutritional profile of children with celiac disease. Indian Pediatr. 2003;40:337-42.
9. Bhatnagar S, Datta S, Mathur M, et al. Celiac disease with mild to moderate histologic changes is a common cause chronic diarrhea in Indian children. J Pediatr Gastroenterol Nutr. 2005;41:204-9.
10. MacDonald T, Spencer J. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J Exp Med. 1988;167:1341-9.
11. Halstensen TS, Scott H, Fansa O, Brandtzaeg P. Gluten stimulation of celiac mucosa in vitro induces activation (CD 25) of lamina propria CD 4+ T cells and macrophages but no crypt cell hyperplasia. Scand J Immunol. 1993;38:581-90.
12. Nilsen EM, Lundin KE, Krajci P, Scott H, Sollid LM, Brandtzaeg P. Gluten specific, HLA DQ restricted T- cells from celiac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma. Gut. 1995;37:766-76.
13. Lahat N, Shapiro S, Karban A, Gerstein R, Kinarty A, Lerner A. Cytokine profile in coeliac disease. Scand J Immunol. 1999;49:441-6.
14. Przemioslo RT, Kontakou M, Nobili V, Ciclitira PJ. Raised proinflammatory cytokines interleukin 6 and tumor necrosis factor alpha in celiac disease mucosa detected by immunohistochemistry. Gut. 1994;35:1398-403.
15. Hansson T, Dannaeus A, Klareskog L. Cytokine- producing cells in peripheral blood of children with celiac disease secrete cytokines with a type 1 profile. Clin Exp Immunol. 1999;116:246-50.
16. Romaldini CC, Barbieri D, Okay TS, Raiz Jr R, Cancado EL. Serum soluble Interleukin-2 receptor, Interleukin-6 and tumor necrosis factorα levels in children with celiac disease: response to treatment. J Pediatr Gastroenterol Nutr. 2002;35:513-7.
17. Working Group of ESPGAN. Revised criteria for diagnosis of Celiac Disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child. 1990;65:909-11.
18. Marsh MN. Immunocytes, enterocytes and the lamina propria: an immunopathological framework of celiac disease. J R Coll Physicians Lond. 1983;17:205-12.
19. Lundin KE, Scott H, Hansen T, Paulsen G, Halstensen TS, Fansa O. Gliadin specific, HLA DQ (alpha 1*0501, beta 1*0201) restricted T-cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med. 1993;178:187-96.
20. Gjersten HA, Sollid LM, Ek J, Thorsby E, Lundin KE. T-cells from the peripheral blood of celiac disease patients recognize gluten antigens when presented by HLA-DR, DQ or DP molecules. Scand J Immunol. 1994;39:567-74.
21. O'Keeffe J, Mills K, Jackson J, Feighery C. T cell proliferation, MHC class II restriction and cytokine products of gliadin stimulated peripheral blood mononuclear cells (PBMC). Clin Exp Immunol. 1999;117:269-76.
22. Baker BS, Garioch JJ, Bokth S, et al. Lack of proliferative response by gluten specific T cells in the blood and gut of patients with dermatitis herpetiformis. J Autoimmun. 1995;8:561-74.
23. Penttila IA, Gibson CE, Forrest BD, Cummins AG, Labrooy JT. Lymphocyte activation as measured by interleukin-2 receptor expression to gluten fraction 3 in coeliac disease. Immunol Cell Biol. 1990;68:155-60.
24. Jelínková L, Tucková L, Sánchez D, et al. Increased levels of circulating ICAM-1, E-Selectin and IL-2R in coeliac disease. Dig Dis Sci. 2000;45:398-402.
25. Srivastava MD, Rossi TM, Lebenthal E. Serum soluble interleukin-2 receptor, soluble CD8 and soluble adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus. Res Commun Mol Pathol Pharmacol. 1995;87:21-6.
26. Blanco A, Garrote JA, Arranz E, Alonso M, Clavo C. Increased serum IL-2R levels in coeliac disease are related to CD 4 but not CD 8 antigens. J Pediatr Gastroenterol Nutr. 1992;15:413-7.
27. Cummins AG, Penttila IA, Labrooy JT, Robb TA, Davidson GP. Recovery of the small intestine in coeliac disease on a gluten free diet: changes in intestinal permeability, small bowel morphology and T- cell activity. J Gastroenterol Hepatol. 1991;6:53-7.
28. Crabtree JE, Heatley RV, Juby LD, Howdle PD, Losowsky MS. Serum interleukin-2 receptor in coeliac disease: response to treatment and gluten challenge. Clin Exp Immunol. 1989;77:345-8.
29. Fornari MC, Pedreira S, Niveloni S, et al. Pre- and post- treatment serum levels of cytokines IL-1beta, IL-6, and IL-1 receptor antagonist in celiac disease. Are they related to the associated osteopenia ? Am J Gastroenterol. 1998;93:413-8.
30. Sturgess RP, Hooper LB, Spencer J, Hung CH, Nelufer JM, Ciclitira PJ. Effects of interferon -gamma and tumor necrosis factor -Alpha on epithelial HLA class-II expression on jejunal mucosal biopsy specimens cultured in vitro. Scand J Gastroenterol. 1992;27:907-11.
31. Gamble JR, Harlan JM, Klebanoff SJ, Vadas M. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA. 1985;82:8667-71.
32. Ming WJ, Bersani L, Mantovani A. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol. 1987;138:1469-74.
33. Yokota S, Geppert TD, Lipsky PE. Enhancement of antigen- and mitogen -induced human T- lymphocyte proliferation by tumor necrosis factor -Alpha. J Immunol. 1988;34:531-6.
34. Pober JS. Warner-Lambert/Parke-Davis award lecture. Cytokine- mediated activation of vascular endothelium, physiology and pathology. Am J Pathol. 1988;133:426-33.
35. Cataldo F, Lio D, Marino V, et al. Groups of the SIGEP and "Club del Tenue". Cytokine genotyping (TNF and IL-10) in patients with celiac disease and selective IgA deficiency. Am J Gastroenterol. 2003;98:850-6.